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It is important to underscore, as pointed out by Curran and
Kolakofsky, that most of our understanding of the mechanisms of
transcription and replication of the genome RNA of non-
segmented negative-strand (NNS) RNA viruses has come from
detailed investigations of the vesicular stomatitis virus (VSV)
system. Following the discovery of the virion-associated tran-
scriptase (Baltimore et al., 1970), VSV provided the paradigm of
the NNS RNA virus and continues to serve as such in studies of
mRNA transcription in vitro. The series of findings that resulted
from the study of VSV has, for over 30 years, essentially formed
the basis for more fully characterizing the mechanisms of gene
expression of the NNS RNA viruses. These studies include the
first demonstration of the synthesis of leader RNA (Colonno and
Banerjee, 1976), ultraviolet-transcriptional mapping and estab-
lishment of gene order (Abraham and Banerjee, 1976; Ball and
White, 1976), reconstitution of transcription with virion L and P
proteins and demonstration of the 3′-entry of the RNA poly-
merase (Emerson, 1982), unconventional mRNA capping reac-
tion (Abraham et al., 1975) and solving the mechanism (Ogino
and Banerjee, 2007), reconstitution of transcription with purified
recombinant L and P proteins (Mathur et al., 1996), and des-
cribing the role of phosphorylation of the P protein in transcription
(Takacs et al., 1992). Despite continued efforts, other viruses of
the NNS RNA virus family remain recalcitrant to similar in vitro
manipulations, which in the VSV system, were carried out with
relative ease. Major findings, particularly in Sendai virus (SeV)
and respiratory syncytial virus (RSV), have come primarily from
in vivo studies using recombinant viruses, minigenomes contain-
ing reporter gene and DI particles using variously engineered
genomic and antigenomic promoters regions (Cowton et al.,
2006; Le Mercier et al., 2003). Since, in these systems, all three
proteins – L, P, and N – need to be synthesized or expressed for
transcription, replication, and encapsidation to occur, it is difficult
to pinpoint which forms of complex (transcriptase or replicase)
indeed carried out specific reactions under certain mutation
conditions. Nevertheless, a good deal of information was gleaned
from such studies regarding the role of cis elements in tran-
scription, replication, and encapsidation reactions.
As articulated by Curran and Kolakofsky, based on the ex-
periments carried out by Emerson (Emerson, 1982), the current
textbook mechanism of VSV (and by extension, of most NNS
RNAviruses) emerged that postulates that the L (RdRp) protein
and the co-factor P enter the 3′-end of the genome RNA
(designated N-RNA template) and transcribes first the leader0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.11.026RNA followed sequentially the rest of the genome in the order N,
P, M, G, and L. Replication of the same N-RNA template, as
postulated (Blumberg et al., 1981), required synthesis of NO
(N protein complexed with P), which presumably interacts with
the nascent leader RNA and by an unknown mechanism
switches the transcriptase function of the polymerase to replicase
with concomitant encapsidation of the newly synthesized anti-
genome RNA. The basic tenet of the proposedmechanism is that
the same polymerase (L and P complex) carries out both tran-
scription and replication, the latter requiring interaction of NO
with the leader RNA.
As correctly stated by Curran and Kolakofsky, two important
observations, again in the VSV system, questioned this long-
standing model. One was from Wertz's laboratory, which de-
monstrated that transcription and replication initiate at separate
sites on the VSV genome in vivo (Whelan and Wertz, 2002),
and the other from our laboratory (Qanungo et al., 2004), which
found that two RNA polymerase complexes from VSV-infected
cells carry out transcription and replication; the (L–P) complex
bound to host proteins initiates at the N-gene start site, and a
putative tripartite complex (L–N–P) (possibly free of host pro-
teins) initiates at the 3′-end and in association with NO repli-
cates end-to-end with concurrent encapsidation of replicated
RNA. Thus, the existence and involvement of two distinct RNA
polymerase complexes were proposed. These postulates led to a
quandary regarding how to reconcile the newer concept with the
prevailing single-entry mechanism.
Based partially on the above findings and findings of their
own in the SeV system, Kolakofsky et al. (2004) previously
proposed a unified model that invoked a new function of the
RNA polymerase, i.e., scanning the 3′-terminal region of the
genome RNA. Based on their unpublished observation (Fig. 1,
the letter) that addition of excess of NO extract to the SeV
nucleocapsids together with (L–P4) containing beads led to
increased replication, Curran and Kolakofsky now propose a
modified version of their previous model (Kolakofsky et al.,
2004) that attempts to accommodate the recent results obtained
from VSV (Qanungo et al., 2004; Whelan and Wertz, 2002). In
this revised model, NO plays a pivotal role in switching the
RNA polymerase from transcriptive to replicative mode such
that it initiates precisely at the 3′-end; whereas in the absence of
NO, the RNA polymerase, once associated with the host pro-
teins, enters initially at the 3′-end (not at the N-gene start site),
scans the leader region, and initiates at the N-gene start site. The
reason for the latter function is postulated since the “RdRp is
relatively inefficient because it must open the N-RNA and load
onto the genome RNA 3′-end without the aid of concomitant
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RdRp complex is inefficient and needs to load onto the 3′-end.
This complex with full complement of P and host proteins is
poised to bind to the leader template, its strong promoter site, at
a location which may not be the 3′-end, but near it (probably at
the N gene start-site), to initiate N-mRNA synthesis. The
replicase, as proposed, binds at the 3′-end and initiates precisely
at the first base. This model maintains that the same polymerase,
i.e., (L–P4) for SeV and (L–P2) for VSV, is engaged in two
functions: as a replicase in the presence of NO and as a
transcriptase in the presence of the host proteins. Replicase and
transcriptase both enter at the 3′-end, but the latter scans and
initiates at the N-gene start site. Arguably, this is a plausible
model, except for the fact that there is no direct demonstration
of scanning by the RdRp in the NNS virus system, although
existence of such phenomena has been implicated particularly at
the intergenic regions of the genome RNA (Kolakofsky et al.,
2004; Cowton et al., 2006).
The major differences between the proposed model and the
“two polymerase complex” model (Qanungo et al., 2004)
involve (a) whether the replicase is a (L–P4)(N
O) complex or a
tripartite (L–N–P) complex and (b) whether the transcriptase,
(L–P4)(host protein), indeed enters at the 3′-end or at a separate
N-gene start site. Let us consider both points separately.
The conclusion that the replicase is a tripartite complex ini-
tially came indirectly from a mini-genome transcription system
wherein a phosphorylation-negative Pmutant failed to transcribe
mRNAs but efficiently replicated defective interfering (DI)
particle RNA (Pattnaik et al., 1997), strongly suggesting that
a transcription-defective P mutant is complexed not with L
but rather via the N–Pmut complex. Subsequently, by immuno-
precipitation in transfected cells, it was shown that L protein
interacts with N, but only in the presence of P or Pmut
(Gupta et al., 2003). Finally, by direct purification of the com-
plex [(L–N–P) bound to NO] fromVSV-infected cells (Qanungo
et al., 2004), the replicase was shown to initiate at the 3′-end in
vitro and synthesized encapsidated RNA in the presence of NO.
Furthermore, in a minus UTP reaction, the replicase synthesized
only the expected 18-mer. The above results are consistent with
the interpretation that the L protein functions as a replicase when
complexed with (NO), which presumably directs it to bind to the
leader template (precise location unknown) and initiates at the
3′-end. It is possible, however, in the absence of NO, that the
replicase may synthesize only the leader RNA; NO is required
for encapsidation of nascent RNA as well as for movement of the
replicase along the template. On the other hand, when L is
complexed with P and host proteins, it functions as a tran-
scriptase, recognizes a separate or overlapping promoter site on
the leader template, and initiates at the N-gene start-site. This
conclusion was supported by the minus UTP reaction when
only the AACAG sequence was discernible (Qanungo et al.,
2004). This model is similar to that proposed by Curran and
Kolakofsky, except that the composition of the replicase com-
plexes is different and the putative scanning event by the
transcriptase is avoided. In this regard, in the experiment
shown in Fig. 1 (the letter), a possibility exists that the (L–P4)
complex may interact with NO to form the putative replicase(L–N–P) complex resulting in replication which can be veri-
fied experimentally.
The last part of the puzzle is why the resident RNA
polymerase of the purified virion synthesizes both leader RNA
and mRNAs initiating from the 3′-end in vitro but not in vivo. It
is important to consider that the resident RNA polymerase,
which is devoid of host proteins, remains tightly bound to the
nucleocapsid, as “frozen in place” (the letter) during the final
stages of assembly and budding of the virions and transcribe the
genome RNA in a processive manner. In contrast, within the
infected cells, there exists a dynamic equilibrium between the
relative amounts of newly synthesized transcriptase and repli-
case and regulated interaction of each of them with the template
leads to either transcription or replication, depending on
template availability. In the experiments by Whelan and Wertz
(2002), it can be envisaged that RdRp once inside the cell
synthesized both leader RNA and mRNAs during the first round
of transcription. The RdRp that synthesized the leader RNA
subsequently fell off the template, never entered the 3′-end being
associated with the host proteins now bound near the N-start site
and synthesized N-mRNA and the downstream genes in
subsequent rounds of processive transcription. Thus, a tangible
difference in the promoter recognition may be manifested by
the RdRp packaged within the virion versus the RdRp bound
to host proteins within the cellular milieu during mRNA
synthesis. Further studies, probably based on investigation of
VSV, may eventually resolve these issues.
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